mRNA - HealthQuill

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA drugs.

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

by HealthQuill
February 3, 2023
0 Comments

Moderna, a US-based biotechnology company, hopeful of cancer vaccine by 2030

Drugs Pharma

Moderna in $35 million licensing deal with CytomX

Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.

by HealthQuill
January 7, 2023
0 Comments

Drugs Medical Pharma

China’s Everest starts first phase operations to make mRNA vaccines

Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.

by HealthQuill
December 28, 2022
0 Comments

Drugs Medical

‘Universal’ Covid-19 treatment may be on the horizon

October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a “universal” method of treating Covid-19. According to.